MENU
SION
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sionna Therapeutics (SION) Ownership - Who owns Sionna Therapeutics?
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
934.31M
P/E Ratio
N/A
Total Cash
269.67M
Projected Growth
N/A
Total Debt
9.5M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.12
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SION
Capitalization
934M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
270M
Total Cash/Share
6.12
Total Debt
9.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
352M
P/B Ratio
2.66
Cash Flow
N/A
Earnings
-1.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
44K
Current Ratio
28.73
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-76.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-17.94
Shares Held By Institutions
435M
Shares Outstanding - Current
44.1M
Total Liabilities
17.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information